Skip to main content

Regulatory and Washington

  • Congressman saluted by HDMA

    ARLINGTON, Va. — The Healthcare Distribution Management Association on Tuesday honored Rep. John Shimkus, R-Ill., with its Rx Safety and Healthcare Leadership Award. The award recognizes public officials for their leadership and commitment to policies that support and promote the safe and efficient delivery of medicines.

  • NRF welcomes consumer groups' opposition to swipe-fee reform delay

    WASHINGTON — Just two weeks after expressing its discouragement caused by the delayed swipe-fee reform, the National Retail Federation lauded a letter from a coalition of consumer groups that also opposed the delay, which is slated to go into effect this summer.

  • APhA, Cardinal Health Foundation join forces to curb Rx abuse

    SEATTLE — The American Pharmacists Association has teamed up with the Cardinal Health Foundation to fight against prescription drug abuse through several initiatives.

    With funding support from the Cardinal Health Foundation, APhA members will take an active role in preventing the abuse and misuse of prescription medications, including the following initiatives:

  • FDA OKs continued compounding of versions of Makena

    SILVER SPRING, Md. — Usually, when the Food and Drug Administration approves a commercial version of a drug, it prohibits compounding pharmacies from producing it, but it’s making an exception in the case of a drug used to prevent premature births.

  • Report: Generic utilization can save Medicaid millions

    WASHINGTON — The American Enterprise Institute for Public Policy Research on Monday published a working paper that identified $329 million in overspending as a result of underutilization of generics.

    As total spending on 20 medicines with generic equivalents totaled approximately $1.5 billion, AEI concluded Medicaid overspent by 22% ($1.5 billion versus $1.17 billion) on these pharmaceuticals.

  • McNeil announces third recall of 2011

    FORT WASHINGTON, Pa. — McNeil Consumer Healthcare on Tuesday recalled one product lot of the analgesic Tylenol 8 Hour extended-release caplets 150-count bottles distributed in the United States, and three brands at the wholesale level.

    “McNeil is taking this action as part of our ongoing surveillance and monitoring efforts that identified a small number of complaints of a musty or moldy odor,” the company stated, specifically referencing only the Tylenol 8 Hour recall. The lot number found on the label on the side of the bottle is ADM074; UPC Code 300450297181.

  • Changing Medicare eligibility age shifts costs to employers, younger seniors

    MENLO PARK, Calif. — Raising Medicare’s eligibility age from 65 to 67 years in 2014 would generate an estimated $7.6 billion in net savings to the federal government, but also would result in an estimated net increase of $5.6 billion in out-of-pocket costs for 65- and 66-year-olds, as well as $4.5 billion in employer retiree healthcare costs, according to a new Kaiser Family Foundation projection of the potential change suggested by several deficit-reduction plans.

  • Report: FDA scientist charged with insider trading

    WASHINGTON — One could say that a job with the Food and Drug Administration would be the perfect way to get information about upcoming drug approvals and use it to profit handsomely from buying stock in the companies that manufacture the drugs before the information reaches the public.

    Of course, the Securities and Exchange Commission would consider that illegal insider trading, as one FDA scientist recently discovered.

X
This ad will auto-close in 10 seconds